CC-122 Degrades the Lymphoid Transcription Factor Aiolos (IKZF3) By Modulating Cereblon and Shows Clinical Activity in a Phase Ib Study of Subjects with Relapsed or Refractory Non-Hodgkin’s Lymphoma and Multiple Myeloma
暂无分享,去创建一个
A. Santoro | D. Rasco | R. Chopra | P. Hagner | W. Edenfield | V. Ribrag | M. Pourdehnad | M. Gironella | A. Stoppa | Xin-Xin Wei | M. Gharibo | A. Gandhi | J. Dimartino | A. James | Silvia Damien